SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Illumina (ILMN) Optics for Genomics
ILMN 121.07-1.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elmer who started this subject10/17/2001 9:55:39 PM
From: mopgcw   of 276
 
From the most recent Goldman Sachs report:

Illumina (ILMN, Market Outperformer) - We maintain our third-quarter loss estimate of $0.18 based on revenues of
$2.6 million, including amortized deferred stock expenses. Our 2001 and 2002 loss estimates of $0.75 and $0.54 per
share, respectively, remain unchanged.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News